Remove 2013 Remove Healthcare Provider Remove Pharma Remove Prescription
article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf. 1435 (“Affordable Prescriptions for Patients Act of 2021”), [link] gov/bill/117th-congress/senate-bill/1435/text; H.R. Actavis, 570 U.S.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Since buying the chain, Amazon has made strategic expansions of its brick-and-mortar locations ( Connecticut , San Francisco , and Milwaukee ), increased IDN partnerships for specialty referrals to 18, and introduced healthcare-focused subscription services, including One Medical and RxPass. healthcare in 2024 appeared first on Clarivate.

Retail 52
article thumbnail

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

In 2013, this changed when an NIH lab reported the structure of the RSV protein, leading to the exploration of the RSV structure in ways that were not previously possible. In those cases, healthcare providers may give preferential recommendations to monoclonal antibodies, she says.

Pharma 64